In summary, strategies aimed at downregulating PrPc expression, including stimulation of ATG-dependent PrPc clearance may produce beneficial effects in cancer in general, and in GBM in particular, by inhibiting CSCs’ stemness, self-renewal, proliferation, invasiveness, and resistance to radio-/chemo-therapy (Figure 3). The gene discussed is PRNP; the disease is glioblastoma.